Loading clinical trials...
Loading clinical trials...
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Monotherapy in Patients With Major Depressive Disorder
Conditions
Interventions
Rapastinel
Placebo
Locations
40
United States
Alea Research
Phoenix, Arizona, United States
Woodland International Research Group
Little Rock, Arkansas, United States
California Pharmaceutical Research Institute, Inc.
Anaheim, California, United States
Collaborative Neuroscience Network
Garden Grove, California, United States
Synergy Research San Diego
National City, California, United States
Excell Research Inc.
Oceanside, California, United States
Start Date
June 15, 2018
Primary Completion Date
July 8, 2019
Completion Date
July 8, 2019
Last Updated
September 1, 2020
NCT05415397
NCT07059234
NCT06396312
NCT06136546
NCT06398496
NCT06417619
Lead Sponsor
Naurex, Inc, an affiliate of Allergan plc
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions